ArticleFrontiers in pharmacology2021

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease.

Florian Lüke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.